These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2684526)

  • 1. Influence of rhEPO therapy on the protein metabolism of hemodialysis patients with terminal renal insufficiency.
    Fischer C; Scigalla P; Park W; Becker H; Schiller R; Paust H; Broesicke H; Kessel M
    Contrib Nephrol; 1989; 76():250-6. PubMed ID: 2684526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of changes in amino acid metabolism in pre-dialysis patients treated with erythropoietin.
    Nishikage H; Kosugi T; Danbara A; Yamamoto J; Matsuo S; Hotta N
    Nephron; 2000 Jul; 85(3):277-8. PubMed ID: 10867545
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency].
    Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B
    Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
    Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
    Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M; Miyazono K; Urabe A; Takaku F
    Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modality of dialysis treatment: does it influence the response to erythropoietin treatment?
    Locatelli F; Del Vecchio L; Andrulli S
    Nephrol Dial Transplant; 2001 Oct; 16(10):1971-4. PubMed ID: 11572880
    [No Abstract]   [Full Text] [Related]  

  • 11. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
    Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal insufficiency and erythropoietin].
    Takaku F
    Nihon Rinsho; 1974 Mar; 32(3):528-34. PubMed ID: 4603797
    [No Abstract]   [Full Text] [Related]  

  • 14. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction of anemia by recombinant human erythropoietin in a patient with polycythemia vera associated with hemodialysis-dependent chronic renal failure.
    Ohyashiki JH; Fujieda H; Ohyashiki K; Toyama K
    Am J Hematol; 1991 Jun; 37(2):141-2. PubMed ID: 2069164
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmacokinetics of recombinant human erythropoietin].
    Siniukhin VN; Stetsiuk EA; Lovchinskiĭ EV; Lebedev SV; Iarmolinskiĭ IS; Liakhov VV
    Ter Arkh; 1994; 66(8):60-2. PubMed ID: 7985158
    [No Abstract]   [Full Text] [Related]  

  • 17. Folic acid supplementation improves erythropoietin response.
    Pronai W; Riegler-Keil M; Silberbauer K; Stockenhuber F
    Nephron; 1995; 71(4):395-400. PubMed ID: 8587618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
    Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K
    Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.